Knockdown studies in ovarian cancer cells suggest that this positive effect of claudin-4 overexpression may be due to its ability to sustain the expression of E-cadherin and limit β-catenin signaling (17,18). This evidence concerns the gene CLDN4 and ovarian cancer.